J vs LAB · P/E 36, $14.40B cap vs rev $174.4M
Jacobs Solutions Inc. (J) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
J does not have a complete income-statement cache yet.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
J currently screens at market cap $14.40B and trailing P/E 36.0. LAB currently screens at market cap $317.1M.
Not investment advice. Open the J and LAB stock pages for the full models.
Not investment advice.